- Announces completion of enrollment in its oral allergen challenge study for the development of its late-stage pipeline program, Anaphylm (epinephrine) Sublingual Film
- Outlines the dev… [+15185 chars]
Lifestyle Natural Medicines
Aquestive Therapeutics Spotlights its Innovative Epinephrine Delivery Pipeline at Virtual Investor Day
WARREN, N.J., Sept. 27, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science
